Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|July 25, 2023
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patientsAxel Muendlein, Christine Heinzle, Eva Maria Brandtner, et al.
Molecular Biology Reports|October 16, 2023
Myricetin attenuates hypoxia-induced inflammation in human adipocytesKathrin Geiger, Axel Muendlein, Andreas Leiherer, et al.
European Journal of Clinical Investigation|November 3, 2025
Angiopoietin-like protein 2 and mortality in patients with heart failure-Results from an observational studyEva Maria Brandtner, Andreas Leiherer, Barbara Larcher, et al.
Oncology Research and Treatment|January 29, 2026
Clinical Prognostic Significance of LRG1 in Metastatic Breast CancerAxel Muendlein, Eva Maria Brandtner, Christine Heinzle, et al.
Plos One|November 1, 2011
Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysisKathrin Geiger, Andreas Leiherer, Axel Muendlein, et al.
International Journal of Cardiology|August 9, 2022
Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery diseaseAxel Muendlein, Christine Heinzle, Andreas Leiherer, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 6, 2025
Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery diseaseAxel Muendlein, Andreas Leiherer, Eva Maria Brandtner, et al.
Atherosclerosis|February 24, 2022
Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patientsAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.
Molecular Biology of the Cell|April 12, 2012
FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastomaKathrin Geiger, Judith Hagenbuchner, Martina Rupp, et al.
Pageof 6